(openPR) - Mauritius-based tertiary care Apollo Bramwell Hospital recently introduced and successfully performed the first clinical procedure using Stem Cells – a First in Mauritius and the Sub Saharan region.
As part of its commitment to enhancing the standard of healthcare in Mauritius, Apollo Bramwell Hospital has shared knowledge on this innovative technology with local doctors.
This was done during a Continuous Medical Education (CME) conference at ABH last night. A tailored schedule was set up so that a maximum knowledge is shared with the Mauritian doctors.
The CME started with the introduction of Stem Cell by Dr. Salah Aljanabi. Dr. Tharun Krishna followed with an exposé on “Clinical Stem Cell Uses in Orthopedic & Sport Injuries,” while Dr. Yassin Hamuth concluded with “Clinical Stem Cell Uses in Cardiovascular & CLI.”
“A stem cell is an undifferentiated cell with self renewal capabilities that can differentiate themselves into other types of cells and proliferate in culture. When stem cells are introduced in the body, they can regenerate the patient’s blood vessels thus avoiding amputations,” explained Dr. Aljanabi.
The Stem Cell Program – a First in Mauritius and the Sub Saharan region – uses the restorative and curative powers of bone marrow stem cells in treating diseases such as obstructed arteries and veins, gangrene, amputation of diabetic foot, heart disease, orthopedic and sports injuries, bone fractures among others. The program has established collaborations with leading university hospital in Germany and France.
“The Stem Cell Department is fully equipped with state-of-the-art equipment managed by dedicated scientist and doctors who received training in the United States, Europe and Australia to provide the latest medical advancement in Stem Cell Therapy to our patients,” said Dr Miodrag Todorovic, Clinical Advisor of Medical Services and Quality Control at Apollo Bramwell.
Apollo Bramwell Hospital has successfully performed the first clinical procedure using Stem Cells.
A 70year old, long-time diabetes patient who was bound for foot amputation, was the first to sign up for the revolutionary treatment.
“The procedure went well and we hope to see visible changes in the weeks to come,” said Dr. Salah Aljanabi, who is heading the Stem Cell Program at ABH.
The patient had originally shown his gangrened right foot to several doctors and healthcare providers but all were adamant that it had to be amputated. “But the results are now clearly visible,” said Dr Krishna.
Statistics available at the Mauritian Ministry of Health show there are around 400 amputations performed every year due to diabetes-related complications, including gangrene. These amputations lead to physical disability and can occasionally cause death.
Dr. Aljanabi holds a PhD in Molecular Genetics from the Iowa State University and has spent more than twenty years in molecular and genetic research. He is supported by Dr Tharun Krishna, Clinical Program Director, Dr Yassin Hamuth and Dr Ziyad Jhumka- Cellular Technologist.

The Apollo Bramwell Hospital in Moka, Mauritius, (apollobramwell.mu) is a 200-bed healthcare venture between Mauritius-based British American Investment and India's Apollo Hospitals Group. Apollo Bramwell Hospital provides the full array of services expected of a Super Specialty Tertiary Care Hospital of international standards. It offers the unique combination of “High Tech and High Touch” - finest technology and medical expertise available worldwide coupled with the human touch of Tender Loving Care (TLC).

Javed Bolah
Media and Communications Manager
British American Investment
25, Pope Hennessy Street, Port Louis
Mauritius
Tel: 230 601 8700
Email: jbolah@bai.intnet.mu